These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Identification of critical regions in human SAMHD1 required for nuclear localization and Vpx-mediated degradation. Guo H; Wei W; Wei Z; Liu X; Evans SL; Yang W; Wang H; Guo Y; Zhao K; Zhou JY; Yu XF PLoS One; 2013; 8(7):e66201. PubMed ID: 23874389 [TBL] [Abstract][Full Text] [Related]
11. Degradation of SAMHD1 by Vpx Is Independent of Uncoating. Jáuregui P; Logue EC; Schultz ML; Fung S; Landau NR J Virol; 2015 May; 89(10):5701-13. PubMed ID: 25762741 [TBL] [Abstract][Full Text] [Related]
12. Suppression of tumor angiogenesis by targeting the protein neddylation pathway. Yao WT; Wu JF; Yu GY; Wang R; Wang K; Li LH; Chen P; Jiang YN; Cheng H; Lee HW; Yu J; Qi H; Yu XJ; Wang P; Chu YW; Yang M; Hua ZC; Ying HQ; Hoffman RM; Jeong LS; Jia LJ Cell Death Dis; 2014 Feb; 5(2):e1059. PubMed ID: 24525735 [TBL] [Abstract][Full Text] [Related]
13. The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. Hofmann H; Logue EC; Bloch N; Daddacha W; Polsky SB; Schultz ML; Kim B; Landau NR J Virol; 2012 Dec; 86(23):12552-60. PubMed ID: 22973040 [TBL] [Abstract][Full Text] [Related]
14. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification. Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the interactions between SIVrcm Vpx and red-capped mangabey SAMHD1. Li J; Xu F; Hu S; Zhou J; Mei S; Zhao X; Cen S; Jin Q; Liang C; Guo F Biochem J; 2015 Jun; 468(2):303-13. PubMed ID: 25791246 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells. Luo Z; Pan Y; Jeong LS; Liu J; Jia L Autophagy; 2012 Nov; 8(11):1677-9. PubMed ID: 22874562 [TBL] [Abstract][Full Text] [Related]
17. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth. Luo Z; Yu G; Lee HW; Li L; Wang L; Yang D; Pan Y; Ding C; Qian J; Wu L; Chu Y; Yi J; Wang X; Sun Y; Jeong LS; Liu J; Jia L Cancer Res; 2012 Jul; 72(13):3360-71. PubMed ID: 22562464 [TBL] [Abstract][Full Text] [Related]
18. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells. Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162 [TBL] [Abstract][Full Text] [Related]
19. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells. Lan H; Tang Z; Jin H; Sun Y Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292 [TBL] [Abstract][Full Text] [Related]
20. Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac. Brandariz-Nuñez A; Valle-Casuso JC; White TE; Laguette N; Benkirane M; Brojatsch J; Diaz-Griffero F Retrovirology; 2012 Jun; 9():49. PubMed ID: 22691373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]